Product logins

Find logins to all Clarivate products below.


Anne Lecocq

Senior Vice President and General Manager, Research & Development

Anne Lecocq is a seasoned life sciences executive with over 20 years of experience. She began her career in the pharmaceutical and generics industries, specializing in regulatory compliance and chemistry, manufacturing and controls (CMC), before joining Clarivate in 2008.

At Clarivate, Anne has held multiple leadership roles overseeing data and content strategy for Cortellis solutions spanning drug discovery, clinical trials, competitive intelligence, safety, and regulatory intelligence. In her current role as General Manager of the R&D Business, she drives product innovation and strategic growth for the Cortellis product suite, enabling biopharma organizations to accelerate the delivery of life-changing therapies to patients through actionable intelligence and advanced analytics.

Anne holds dual master’s degrees in Biotechnology & Chemistry and Regulatory Affairs. Based in Paris, France, she is passionate about leveraging her multidisciplinary expertise to advance global R&D efficiency through transformative intelligence.

Latest news

News February 3, 2026
Clarivate Webinar “Intelligence Amplified in the Age of AI” Highlights How Trusted, Proprietary Data Powers Next Generation Innovation

London, UK – February 3, 2026, Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of a video webinar, Intelligence Amplified in the Age…

News February 2, 2026
Clarivate Announces Full Redemption of Remaining $100 Million Senior Secured Notes Due 2026 and Provides Update on Capital Allocation Activities

London, UK – February 2, 2026, Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that its subsidiary, Camelot Finance S.A., has redeemed the remaining $100…

News January 28, 2026
Clarivate to Report Fourth Quarter and Full Year 2025 Results on February 24, 2026

London, U.K., January 28, 2026 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the fourth…

Related resources

Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center
The trends to watch in 2025 The trends to watch in 2025
Blog January 8, 2025
The trends to watch in 2025